Janus
Log In
Log Out
Ticker Symbol:
JNGLX
Fund Type:
  

Management Fee Evaluation


Class D shares

   
Who should consider this fund

Investors looking for exposure to a fast-growing area of the overall market through companies that we believe are either driving advancements in the healthcare field or benefiting from demographic trends

  • Global approach to companies that are addressing unmet medical needs and providing efficient and cost-effective healthcare solutions
  • Differentiated fundamental research -- we seek to understand the science and the business
  • Disciplined valuation analysis and diversification across industries, geographies and market capitalization
Andrew Acker
  • Joined Janus in 1999
  • Andrew is a CFA Charterholder
  • Bachelor's degree - biochemical sciences, Harvard College, graduating magna cum laude and Phi Beta Kappa
  • M.B.A. from Harvard Business School

 

 

as of 04/30/2015
More